P072: Non-invasive Metabolic MR fingerprinting for characterization of brain tumors and cerebral vascular disease
FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.06.2021
End date : 31.05.2022
Project details
Scientific Abstract
The scientific aim of this work is to further develop the metabolic chemical exchange saturation transer MR fingerprinting (CEST MRF) and to translate it from previous animal experiments to human MRI scanners at 3T and 7T. This will enable accelerated quantitative CEST imaging that forms a metabolic MR fingerprinting approach, which can then be evaluated for its potential clinical benefit for tumor diagnosis and stroke prognosis at University Clinic Erlangen.
Involved:
Contributing FAU Organisations:
Interdisziplinäres Zentrum für Klinische Forschung (IZKF)
Professur für Multimodale Bildgebung in der klinischen Forschung
Medizinische Fakultät
